BRICKELL BIOTECH INC has a total of 20 patent applications. It decreased the IP activity by 83.0%. Its first patent ever was published in 2009. It filed its patents most often in Australia, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are NANJING HERON PHARMACEUTICAL SCIENCE AND TECH CO LTD, KREPELKA JIRI and EMISPHERE TECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Brazil | 1 | |
#8 | Hong Kong | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Consumer goods | |
#5 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Abel Ulrich | 6 |
#2 | Stearns Brian Andrew | 5 |
#3 | Takaoka Masayoshi | 4 |
#4 | Brinkman Herbert | 4 |
#5 | Alzenstat Aron | 4 |
#6 | Koleng John | 4 |
#7 | Nagao Tatsuro | 4 |
#8 | Sklawer Andrew | 3 |
#9 | Bor Adam | 3 |
#10 | Repasi Jozsef | 3 |
Publication | Filing date | Title |
---|---|---|
KR20180135447A | Synthesis of (2E, 4E, 6Z, 8E) -8- (3,4-dihydronaphthalene-1 (2H) -ylidene) -3,7-dimethylocta-2,4,6- | |
US2015259283A1 | Formulation for soft anticholinergic analogs |